ID BMAL1_MESAU Reviewed; 626 AA. AC O88529; DT 15-AUG-2003, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1998, sequence version 1. DT 01-APR-2015, entry version 105. DE RecName: Full=Aryl hydrocarbon receptor nuclear translocator-like protein 1; DE AltName: Full=Brain and muscle ARNT-like 1; GN Name=ARNTL; Synonyms=BMAL1; OS Mesocricetus auratus (Golden hamster). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Cricetidae; Cricetinae; Mesocricetus. OX NCBI_TaxID=10036; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=9616112; DOI=10.1126/science.280.5369.1564; RA Gekakis N., Staknis D., Nguyen H.B., Davis F.C., Wilsbacher L.D., RA King D.P., Takahashi J.S., Weitz C.J.; RT "Role of the CLOCK protein in the mammalian circadian mechanism."; RL Science 280:1564-1569(1998). CC -!- FUNCTION: Transcriptional activator which forms a core component CC of the circadian clock. The circadian clock, an internal time- CC keeping system, regulates various physiological processes through CC the generation of approximately 24 hour circadian rhythms in gene CC expression, which are translated into rhythms in metabolism and CC behavior. It is derived from the Latin roots 'circa' (about) and CC 'diem' (day) and acts as an important regulator of a wide array of CC physiological functions including metabolism, sleep, body CC temperature, blood pressure, endocrine, immune, cardiovascular, CC and renal function. Consists of two major components: the central CC clock, residing in the suprachiasmatic nucleus (SCN) of the brain, CC and the peripheral clocks that are present in nearly every tissue CC and organ system. Both the central and peripheral clocks can be CC reset by environmental cues, also known as Zeitgebers (German for CC 'timegivers'). The predominant Zeitgeber for the central clock is CC light, which is sensed by retina and signals directly to the SCN. CC The central clock entrains the peripheral clocks through neuronal CC and hormonal signals, body temperature and feeding-related cues, CC aligning all clocks with the external light/dark cycle. Circadian CC rhythms allow an organism to achieve temporal homeostasis with its CC environment at the molecular level by regulating gene expression CC to create a peak of protein expression once every 24 hours to CC control when a particular physiological process is most active CC with respect to the solar day. Transcription and translation of CC core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, CC PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm CC generation, whereas delays imposed by post-translational CC modifications (PTMs) are important for determining the period CC (tau) of the rhythms (tau refers to the period of a rhythm and is CC the length, in time, of one complete cycle). A diurnal rhythm is CC synchronized with the day/night cycle, while the ultradian and CC infradian rhythms have a period shorter and longer than 24 hours, CC respectively. Disruptions in the circadian rhythms contribute to CC the pathology of cardiovascular diseases, cancer, metabolic CC syndromes and aging. A transcription/translation feedback loop CC (TTFL) forms the core of the molecular circadian clock mechanism. CC Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or CC ARNTL2/BMAL2, form the positive limb of the feedback loop, act in CC the form of a heterodimer and activate the transcription of core CC clock genes and clock-controlled genes (involved in key metabolic CC processes), harboring E-box elements (5'-CACGTG-3') within their CC promoters. The core clock genes: PER1/2/3 and CRY1/2 which are CC transcriptional repressors form the negative limb of the feedback CC loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 CC heterodimer inhibiting its activity and thereby negatively CC regulating their own expression. This heterodimer also activates CC nuclear receptors NR1D1/2 and RORA/B/G, which form a second CC feedback loop and which activate and repress ARNTL/BMAL1 CC transcription, respectively. ARNTL/BMAL1 positively regulates CC myogenesis and negatively regulates adipogenesis via the CC transcriptional control of the genes of the canonical Wnt CC signaling pathway. Plays a role in normal pancreatic beta-cell CC function; regulates glucose-stimulated insulin secretion via the CC regulation of antioxidant genes NFE2L2/NRF2 and its targets SESN2, CC PRDX3, CCLC and CCLM. Negatively regulates the mTORC1 signaling CC pathway; regulates the expression of MTOR and DEPTOR. Controls CC diurnal oscillations of Ly6C inflammatory monocytes; rhythmic CC recruitment of the PRC2 complex imparts diurnal variation to CC chemokine expression that is necessary to sustain Ly6C monocyte CC rhythms. Regulates the expression of HSD3B2, STAR, PTGS2, CYP11A1, CC CYP19A1 and LHCGR in the ovary and also the genes involved in hair CC growth. Plays an important role in adult hippocampal neurogenesis CC by regulating the timely entry of neural stem/progenitor cells CC (NSPCs) into the cell cycle and the number of cell divisions that CC take place prior to cell-cycle exit. Regulates the circadian CC expression of CIART and KLF11. The CLOCK-ARNTL/BMAL1 heterodimer CC regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CC CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, CC F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes CC implicated in glucose and lipid metabolism. Represses CC glucocorticoid receptor NR3C1/GR-induced transcriptional activity CC by reducing the association of NR3C1/GR to glucocorticoid response CC elements (GREs) via the acetylation of multiple lysine residues CC located in its hinge region. Promotes rhythmic chromatin opening, CC regulating the DNA accessibility of other transcription factors. CC The NPAS2-ARNTL/BMAL1 heterodimer positively regulates the CC expression of MAOA, F7 and LDHA and modulates the circadian rhythm CC of daytime contrast sensitivity by regulating the rhythmic CC expression of adenylate cyclase type 1 (ADCY1) in the retina. CC {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- ENZYME REGULATION: The redox state of the cell can modulate the CC transcriptional activity of the CLOCK-ARNTL/BMAL1 and NPAS2- CC ARNTL/BMAL1 heterodimers; NADH and NADPH enhance the DNA-binding CC activity of the heterodimers. {ECO:0000250|UniProtKB:O00327}. CC -!- SUBUNIT: Component of the circadian clock oscillator which CC includes the CRY1/2 proteins, CLOCK or NPAS2, ARNTL/BMAL1 or CC ARNTL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS and the PER1/2/3 CC proteins. Efficient DNA binding requires dimerization with another CC bHLH protein. Heterodimerization with CLOCK is required for E-box- CC dependent transactivation, for CLOCK nuclear translocation and CC degradation, and, for phosphorylation of both CLOCK and CC ARNTL/BMAL1. Part of a nuclear complex which also includes CC GNB2L1/RACK1 and PRKCA; GNB2L1 and PRKCA are recruited to the CC complex in a circadian manner. Interacts with NPAS2, HSP90, AHR, CC CIART, DDX4, SUMO3, OGT, EED, EZH2, SUZ12, KAT2B, EP300, CC BHLHE40/DEC1, BHLHE41/DEC2, ID1, ID2, ID3, MTA1 and SIRT1. CC Interacts with RELB and the interaction is enhanced in the CC presence of CLOCK. Interacts with PER1, PER2, CRY1 and CRY2 and CC this interaction requires a translocation to the nucleus. CC Interaction of the CLOCK-ARNTL/BMAL1 heterodimer with PER or CRY CC inhibits transcription activation. Interaction of the CLOCK- CC ARNTL/BMAL1 with CRY1 is independent of DNA but with PER2 is off CC DNA. The CLOCK-ARNTL/BMAL1 heterodimer interacts with GSK3B. CC Interacts with KDM5A. Interacts with KMT2A in a circadian manner. CC Interacts with UBE3A and PRKCG. Interacts with MAGEL2. Interacts CC with NCOA2. Interacts with THRAP3. {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE- CC ProRule:PRU00981}. Cytoplasm {ECO:0000250|UniProtKB:Q9WTL8}. CC Nucleus, PML body {ECO:0000250|UniProtKB:Q9WTL8}. Note=Shuttles CC between the nucleus and the cytoplasm and this nucleocytoplasmic CC shuttling is essential for the nuclear accumulation of CLOCK, CC target gene transcription and the degradation of the CLOCK- CC ARNTL/BMAL1 heterodimer. The sumoylated form localizes in the PML CC body. Sequestered to the cytoplasm in the presence of ID2. CC {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- PTM: Ubiquitinated, leading to its proteasomal degradation. CC {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- PTM: O-glycosylated; contains O-GlcNAc. O-glycosylation by OGT CC prevents protein degradation by inhibiting ubiquitination. It also CC stabilizes the CLOCK-ARNTL/BMAL1 heterodimer thereby increasing CC CLOCK-ARNTL/BMAL1-mediated transcription of genes in the negative CC loop of the circadian clock such as PER1/2/3 and CRY1/2. CC {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- PTM: Acetylated on Lys-538 upon dimerization with CLOCK. CC Acetylation facilitates CRY1-mediated repression. Deacetylated by CC SIRT1, which may result in decreased protein stabilty. CC {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- PTM: Phosphorylated upon dimerization with CLOCK. Phosphorylation CC enhances the transcriptional activity, alters the subcellular CC localization and decreases the stability of the CLOCK-ARNTL/BMAL1 CC heterodimer by promoting its degradation. Phosphorylation shows CC circadian variations in the liver with a peak between CT10 to CC CT14. Phosphorylation at Ser-90 by CK2 is essential for its CC nuclear localization, its interaction with CLOCK and controls CC CLOCK nuclear entry. {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- PTM: Sumoylated on Lys-259 upon dimerization with CLOCK. CC Predominantly conjugated to poly-SUMO2/3 rather than SUMO1 and the CC level of these conjugates undergo rhythmic variation, peaking at CC CT9-CT12. Sumoylation localizes it exclusively to the PML body and CC promotes its ubiquitination in the PML body, ubiquitin-dependent CC proteasomal degradation and the transcriptional activity of the CC CLOCK-ARNTL/BMAL1 heterodimer. {ECO:0000250|UniProtKB:Q9WTL8}. CC -!- SIMILARITY: Contains 1 bHLH (basic helix-loop-helix) domain. CC {ECO:0000255|PROSITE-ProRule:PRU00981}. CC -!- SIMILARITY: Contains 1 PAC (PAS-associated C-terminal) domain. CC {ECO:0000305}. CC -!- SIMILARITY: Contains 2 PAS (PER-ARNT-SIM) domains. CC {ECO:0000255|PROSITE-ProRule:PRU00140}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF070917; AAC23606.1; -; mRNA. DR RefSeq; NP_001268496.1; NM_001281567.1. DR IntAct; O88529; 1. DR GeneID; 101835598; -. DR CTD; 406; -. DR HOVERGEN; HBG107503; -. DR GO; GO:0033391; C:chromatoid body; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell. DR GO; GO:0005667; C:transcription factor complex; ISS:UniProtKB. DR GO; GO:0001047; F:core promoter binding; ISS:UniProtKB. DR GO; GO:0003677; F:DNA binding; ISS:UniProtKB. DR GO; GO:0070888; F:E-box binding; ISS:UniProtKB. DR GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB. DR GO; GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro. DR GO; GO:0004871; F:signal transducer activity; IEA:InterPro. DR GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB. DR GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB. DR GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB. DR GO; GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB. DR GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB. DR GO; GO:0090403; P:oxidative stress-induced premature senescence; ISS:UniProtKB. DR GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB. DR GO; GO:0042753; P:positive regulation of circadian rhythm; ISS:UniProtKB. DR GO; GO:2001016; P:positive regulation of skeletal muscle cell differentiation; ISS:UniProtKB. DR GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB. DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB. DR GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB. DR GO; GO:2000772; P:regulation of cellular senescence; ISS:UniProtKB. DR GO; GO:0042634; P:regulation of hair cycle; ISS:UniProtKB. DR GO; GO:0050796; P:regulation of insulin secretion; ISS:UniProtKB. DR GO; GO:0050767; P:regulation of neurogenesis; ISS:UniProtKB. DR GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB. DR GO; GO:2000074; P:regulation of type B pancreatic cell development; ISS:UniProtKB. DR GO; GO:0051775; P:response to redox state; ISS:UniProtKB. DR GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB. DR GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW. DR Gene3D; 4.10.280.10; -; 1. DR InterPro; IPR011598; bHLH_dom. DR InterPro; IPR001067; Nuc_translocat. DR InterPro; IPR001610; PAC. DR InterPro; IPR000014; PAS. DR InterPro; IPR013767; PAS_fold. DR Pfam; PF00010; HLH; 1. DR Pfam; PF00989; PAS; 1. DR PRINTS; PR00785; NCTRNSLOCATR. DR SMART; SM00353; HLH; 1. DR SMART; SM00086; PAC; 1. DR SMART; SM00091; PAS; 2. DR SUPFAM; SSF47459; SSF47459; 1. DR SUPFAM; SSF55785; SSF55785; 3. DR TIGRFAMs; TIGR00229; sensory_box; 1. DR PROSITE; PS50888; BHLH; 1. DR PROSITE; PS50112; PAS; 2. PE 2: Evidence at transcript level; KW Acetylation; Activator; Biological rhythms; Cytoplasm; DNA-binding; KW Isopeptide bond; Nucleus; Phosphoprotein; Repeat; Transcription; KW Transcription regulation; Ubl conjugation. FT CHAIN 1 626 Aryl hydrocarbon receptor nuclear FT translocator-like protein 1. FT /FTId=PRO_0000127157. FT DOMAIN 72 125 bHLH. {ECO:0000255|PROSITE- FT ProRule:PRU00981}. FT DOMAIN 143 215 PAS 1. {ECO:0000255|PROSITE- FT ProRule:PRU00140}. FT DOMAIN 326 396 PAS 2. {ECO:0000255|PROSITE- FT ProRule:PRU00140}. FT DOMAIN 401 444 PAC. FT REGION 508 588 Interaction with CIART. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT MOTIF 36 41 Nuclear localization signal. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT MOTIF 142 152 Nuclear export signal 1. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT MOTIF 361 369 Nuclear export signal 2. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT MOD_RES 17 17 Phosphoserine; by GSK3-beta. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT MOD_RES 21 21 Phosphothreonine; by GSK3-beta. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT MOD_RES 90 90 Phosphoserine; by CK2. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT MOD_RES 538 538 N6-acetyllysine. FT {ECO:0000250|UniProtKB:Q9WTL8}. FT CROSSLNK 252 252 Glycyl lysine isopeptide (Lys-Gly) FT (interchain with G-Cter in SUMO2 and FT SUMO3). {ECO:0000250|UniProtKB:Q9WTL8}. FT CROSSLNK 259 259 Glycyl lysine isopeptide (Lys-Gly) FT (interchain with G-Cter in SUMO). FT {ECO:0000250|UniProtKB:Q9WTL8}. SQ SEQUENCE 626 AA; 68701 MW; 65FDD28B38F1E016 CRC64; MADQRMDISS TISDFMSPGP TDLLSSSLGT SGVDCNRKRK GSATDYQESM DTDKDDPHGR LEYAEHQGRI KNAREAHSQI EKRRRDKMNS FIDELASLVP TCNAMSRKLD KLTVLRMAVQ HMKTLRGATN PYTEANYKPT FLSDDELKHL ILRAADGFLF VVGCDRGKIL FVSESVFKIL NYSQNDLIGQ SLFDYLHPKD IAKVKEQLSS SDTAPRERLI DAKTGLPVKT DITPGPSRLC SGARRSFFCR MKCNRPSVKV EDKDFASTCS KKKADRKSFC TIHSTGYLKS WPPTKMGLDE DNEPDNEGCN LSCLVAIGRL HSHVVPQPVN GEIRVKSMEY VSRHAIDGKF VFVDQRATAI LAYLPQELLG TSCYEYFHQD DIGHLAECHR QVLQTREKIT TNCYKFKIKD GSFITLRSRW FSFMNPWTKE VEYIVSTNTV VLANVLEGGD PTFPQLTASP HSMDSMLPSG EGGPKRTHPT VPGIPGGTRA GAGKIGRMIA EEIMEIHRIR GSSPSSCGSS PLNITSTPPP DASSPGGKKI LNGGTPDIPS TGLLPGQAQE TPGYPYSDSS SILGENPHIG IDMIDNDQGS SSPSNDEAAM AVIMSLLEAD AGLGGPVDFS DLPWPL //